STOCK TITAN

MiNK Therapeutics (INKT) Revenue by Year

INKT NASDAQ

MiNK Therapeutics, Inc. does not report revenue for fiscal year 2025, so the figure is not reported on this page. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters MiNK Therapeutics, Inc. has filed alongside them.

FY2025 annual
Revenue N/A
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

INKT Revenue by Fiscal Year

Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-K
RevenueN/AN/AN/AN/AN/AN/A

INKT Revenue by Quarter

Figures are in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-K
Revenue$200Kn/mN/AN/AN/A$0N/AN/AN/AN/AN/AN/AN/A

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More MiNK Therapeutics, Inc. financials

Frequently Asked Questions

MiNK Therapeutics, Inc. does not report revenue for fiscal year 2025, so the figure is not reported on this page.

MiNK Therapeutics, Inc. (INKT) reported $200K in revenue in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what MiNK Therapeutics, Inc. (INKT) reported on that line in every period on record.